List of the consulted stakeholders
|
ACSS – Central Administration of the Health System, P.I. |
ENSP-NOVA – National School of Public Health, New University of Lisbon |
|
ADIFA – Association of Pharmaceutical Distributors |
FFUC – Faculty of Pharmacy, University of Coimbra |
|
AGEAS Portugal – Insurance Company |
FFUL – Faculty of Pharmacy, University of Lisbon |
|
APDP – Diabetes Protection Association of Portugal |
FFUP – Faculty of Pharmacy, University of Porto |
|
APEF – Portuguese Association of Pharmacy Students |
FIP – International Pharmaceutical Federation |
|
APIFARMA – Portuguese Pharmaceutical Industry Association |
FPP – Portuguese Lung Foundation |
|
APJF – Portuguese Association of Young Pharmacists |
Luz Saúde Group |
|
APOGEN – Portuguese Association of Generic and Biosimilar Medicines |
IMHT – Institute of Hygiene and Tropical Medicine |
|
APORMED – Portuguese Association of Medical Devices Companies |
IPU – Irish Pharmacy Union |
|
Oeiras Municipal Council |
Multicare – Health Insurance |
|
Lisbon Municipal Council |
Pharmacists' Order |
|
Porto Municipal Council |
Medical Association |
|
CPE – Community Pharmacy England |
PGEU – Pharmaceutical Group of the European Union |
|
CUF – Health Services, Administrative and Operational |
SPEM – Portuguese Society of Multiple Sclerosis |
|
Directorate-General of Health |
The Pharmacy Guild of Australia |